Pharmaceutical Market Europe • April 2026 • 38
APPOINTMENTS
Lucid Group
Rod MacKenzie
Lucid Group has announced that Rod MacKenzie, former Executive Vice President and Chief Development Officer at Pfizer, has been appointed as the new Chair of the Lucid Group Board of Directors.
MacKenzie spent 34 years at Pfizer, where he led the Global Product Development division and oversaw 6,000 professionals dedicated to advancing innovative medicines and vaccines. He played a critical role in the development of both the Pfizer-BioNTech COVID-19 vaccine and antiviral, Paxlovid, in addition to serving on Pfizer’s Executive Leadership Team from 2016 to 2022.
MacKenzie’s leadership marks a pivotal step in Lucid’s next phase of growth, strengthening its ability to translate complex science into real-world impact. He succeeds Andy Black, who retired from the Board following the end of his term.
OPEN Health
Tim Perryman
OPEN Health has appointed Tim Perryman as Global Head of Operations, strengthening the company’s operational leadership as it continues to scale its global capabilities and support clients navigating increasingly complex decisions across the healthcare landscape.In his role, Perryman will focus on strengthening operational foundations across the organisation, advancing operating models, and enhancing collaboration and efficiency to support OPEN Health’s continued global growth. Perryman brings extensive experience in operational leadership across complex, global organisations. Known for his collaborative leadership style and focus on translating strategy into practical execution, he has a strong track record of building high-performing teams and implementing operational frameworks that support sustainable growth.
Prime
David Hogben
Prime has appointed David Hogben as SVP, Omnichannel Strategy & Delivery.
Based in the US, David has global experience in omnichannel strategy, digital transformation and data-enabled medical communications and will play a key role in embedding the company’s unique omnichannel blueprint into day-to-day operations, strengthening execution across accounts and ensuring the teams deliver omnichannel excellence.
Hogben has led major transformation programmes, enterprise frameworks and digital initiatives across the US and global markets and he will add a critical new dimension to the company’s differentiated omnichannel capability – focusing specifically on helping the scientific and medical communications teams translate strategy into delivery.
Oglivy Health
Aimee Mosher
Ogilvy Health has appointed Aimee Mosher as Chief Client Officer. With over 20 years in healthcare marketing, Mosher has a proven track record of fostering strong client relationships and driving growth. Her deeply human-centric approach aligns seamlessly with our commitment to client excellence. Mosher was previously EVP, Managing Partner at Science & Purpose.
Langland
Andrew Morley
Langland has appointed Andrew Morley as Executive Creative Director. With a passion for convention-busting ideas and a belief in creativity as the most powerful differentiator in healthcare, Morley will lead creative excellence across advertising, clinical trial experience, medical strategy & education and PR – helping shape the next era of standout, human-centred health brands.
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services